Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Hinxton

Curating the Clinical Genome Conference

This event will explore best practices for the clinical application of genomic data, focusing on variant interpretation, clinical utility, and the development of consensus-curated knowledge. [...]

Hinxton

Multiomics in Metabolic Disease

Genetic and biological factors significantly influence the risk of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Advances in ‘omics’ technologies—genomics, epigenomics, transcriptomics, [...]

Hinxton

K-mer Workshop for Biodiversity Genomics

K-mers are a fundamental and versatile tool in bioinformatics, offering powerful solutions to various challenges in genomics. This workshop is designed to equip researchers with [...]

Go to Top